TAVI Hotline: new devices, new approaches

Presentations available when logged in:

• First report of an IDE pivotal study of a dedicated splitting device during TAVR
• Upper extremity versus lower extremity for accessory access sites during TAVI
• DurAVR biomimetic transcatheter heart valve: early feasibility and first-in-human trial update
• One-year efficacy and safety of the dry-pericardium aortic valve: A first-in-human feasibility study
• Using temporary permanent pacemaker as a one-month bridge after TAVI
• Clinical evaluation of the Hydra self-expanding THV: 30 days results from the GENESIS-II study